ETF Opportunities Trust Brendan Wood TopGun Index ETF (BATS: BWTG)

Últimas noticias sobre ETF Opportunities Trust Brendan Wood TopGun Index ETF (BATS:BWTG)

Technology

Financial Services

Industrials

Healthcare

Consumer Cyclical

Real Estate

Consumer Defensive

Other

Communication Services

The Fund seeks to achieve its investment objective by investing, under normal market circumstances, a substantial portion of its assets in publicly listed equity securities included in a model portfolio provided by the Funds investment sub-adviser (Model).

Nvidia Corp.

Crowdstrike Holdings Inc

Asml Holding Nv Adr

Alphabet Inc.

Amazon.Com Inc

Costco Wholesale Corp

Progressive Corp.

Transdigm Group Incorporated

Microsoft Corp

Jpmorgan Chase & Co (jpm)

Brendan Wood TopGun ETF

Equities

Large Cap

News

BWTG

Royal Bank of Canada y Cohere están revolucionando los servicios financieros con su plataforma de IA generativa segura, North for Banking.

Royal Bank of Canada y Cohere desarrollan plataforma de IA generativa para servicios financieros

ETF Opportunities Trust Brendan Wood TopGun Index ETF

ITCI

Intra-cellular Therapies Says It Has Entered Into A Settlement Agreement With Sandoz Inc. Resolving Patent Litigation Related To Intra-cellular Therapies' Product Caplyta (Lumateperone)

Expect March quarter revenue growth of 7 to 9 percent with earnings of $0.70 to $1.00 per share&nbsp;

Earnings

Guidance

Delta Air Lines Expects Q1 2025 Total Revenue Growth Of 7%-9%, Operating Margin Of 6%-8%, And EPS Of $0.700-$1.00 (Est $0.83)

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Endeavour Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXK#NYSE">EXK</a>) with a Buy and lowers the price target from $7.25 to $7.

Price Target

Analyst Ratings

HC Wainwright & Co. Maintains Buy on Endeavour Silver, Lowers Price Target to $7

Morgan Stanley analyst Devin McDermott initiates coverage on Civitas Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) with a Overweight rating and announces Price Target of $64.

Initiation

CIVI

Morgan Stanley Initiates Coverage On Civitas Resources with Overweight Rating, Announces Price Target of $64

Connexa Sports Technologies Inc. - Common Stock

YYAI

Connexa Sports Technologies Sports Technologies Files For Mixed Shelf Offering Of Up To $300M

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact On Multiple Measures Of Myotonic Dystrophy Type 1; Company Plans To Initiate Registrational Expansion Cohort To Support Potential Submission For U.S. Accelerated Approval For DYNE-101 in DM1 In H1 2026

Morgan Stanley analyst Matthew Harrison upgrades Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) from Equal-Weight to Overweight and raises the price target from $87 to $113.

Upgrades

GILD

Morgan Stanley Upgrades Gilead Sciences to Overweight, Raises Price Target to $113

Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) reported quarterly earnings of $1.85 per share which beat the analyst consensus estimate of $1.76 by 5.11 percent. This is a 44.53 percent increase over earnings of $1.28 per share from the same period last year. The company reported quarterly sales of $14.437 billion which beat the analyst consensus estimate of $14.212 billion by 1.58 percent. This is a 1.50 percent increase over sales of $14.223 billion the same period last year.

Earnings Beats

Delta Air Lines Q4 2024 Adj. EPS $1.85 Beats $1.76 Estimate, Sales $14.437B Beat $14.212B Estimate

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates EMX Royalty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EMX#AMEX">EMX</a>) with a Buy and maintains $7 price target.

Reiteration

HC Wainwright & Co. Reiterates Buy on EMX Royalty, Maintains $7 Price Target

Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) discussed its priorities for 2025 with Citi Research analyst Christopher Danely, which includes the company&#8217;s AI ambitions, solving CPU manufacturing issues, and the appointment of a new CEO.
What Happened: David Zinsner and Michelle Johnston Holthaus were named as the interim co-CEOs of Intel on Dec. 2, 2024, while the company searched for a permanent replacement. Former CEO Pat Gelsinger retired and stepped down from the board after over 40 years with the company.
Citi Research, in its research note dated Jan. 9, 2025, highlighted how it plans to work on the most pressing matters in the new year. This includes fixing the product roadmap, fixing CPU manufacturing, and establishing a meaningful foothold in the AI market.
The note also stated that the company will streamline its operations with a goal to gain market share in the CPU market in 2025. Citi reiterated its beliefs in Intel&#8217;s priorities.
Talking about the search for a new CEO, the research note added &#8220;We believe Intel could announce a new CEO within a couple of months and reiterate our Neutral rating.&#8221; The price target remained unchanged at $22 per share, assigned on Nov. 26, 2024.
See Also:<a href="https://www.benzinga.com/markets/equities/24/12/42378342/intel-stock-is-where-it-was-27-years-ago-how-the-worlds-leading-chipmaker-lost-the-plot-thrice"> Intel Stock Is Where It Was 27 Years Ago: How The World&#8217;s Leading Chipmaker Lost The Plot, Thrice</a> 
Why It Matters: Intel&#8217;s market capitalization has significantly lagged behind its competitors.
While Intel&#8217;s value stands at $85.7 billion, Qualcomm Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) market cap stands at $176.7 billion. Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), a key rival, boasts a market capitalization that is more than double of Intel&#8217;s at $197.7 billion.
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) towers above them all with a staggering market capitalization of $3.43 trillion, highlighting the significant gap in valuation within the semiconductor industry.
Additionally, Intel&#8217;s 13th and 14th-generation processors were plagued by persistent performance issues. In August 2024, the chip maker announced plans to cut 15% of its workforce, or about <a href="https://www.benzinga.com/government/24/08/40230583/intels-8-5b-government-windfall-fails-to-stop-15-000-layoffs-at-chipmaker">15,000 jobs</a>, despite receiving $8.5 billion in grants from the U.S. government.
Price Action: Intel&#8217;s stock was down 0.4% in premarket on Friday. The stock has declined by 42.99% over the last six months and by 58.12% over a year. Whereas, the Nasdaq 100 has outperformed with gains of 2.45% in the last six months and 26.13% over a year.
About 31 analysts <a href="https://www.benzinga.com/quote/INTC/analyst-ratings">tracked </a>by Benzinga have a consensus rating of &#8220;sell&#8221; with an average target price of $30.23 on Intel stock. BofA Securities, Northland Capital Markets, and Mizuho are among the three most recent analyst ratings, and their average price target stands at $24, implying a 20.85% upside.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/INTC/analyst-ratings"><img loading="lazy" decoding="async" width="942" height="355" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10045014/INTC-ANR.png" alt="" class="wp-image-727565" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10045014/INTC-ANR.png 942w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10045014/INTC-ANR-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10045014/INTC-ANR-768x289.png 768w" sizes="(max-width: 942px) 100vw, 942px" /></a></figure>
Read Next:
<ul>
<li><a href="https://benzinga.com/markets/equities/25/01/42906089/california-wildfires-ignite-concerns-for-insurance-stocks-here-are-some-insurance-etfs-which-could-be-impacted">California Wildfires Ignite Concerns For Insurance Stocks: Here Are Some Insurance ETFs Which Could Be Impacted </a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Markets

INTC

NVDA

QCOM

Intel Stock Has Fallen Over 58% In 1 Year, But Citi Maintains 'Neutral' Rating On Expected Replacement Of Pat Gelsinger In A 'Couple Of Months'

Needham analyst Matthew Sheerin initiates coverage on Evolent Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) with a Buy rating and announces Price Target of $15.

Needham Initiates Coverage On Evolent Health with Buy Rating, Announces Price Target of $15

On Thursday, January 9th, U.S. markets were closed in a mark of respect for the late former President Jimmy Carter.
U.S. Futures at 06:00 AM ET
<ul>
<li>Dow futures were down 0.10%, S&amp;P 500 futures fell 0.21% and Nasdaq 100 futures declined 0.23%.</li>
<li>U.S. stock futures dipped, weighed by Fed hawkishness, labor market strength, and inflation concerns. Markets await December payrolls for rate cues. Earnings season and rising oil prices add focus.</li>
</ul>
Asia Markets Today
<ul>
<li>On Friday, Japan&#8217;s Nikkei 225 closed lower by 1.04% at 39,208.50, led by losses in the Shipbuilding, Power, and Insurance sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 fell 0.42%, ending the session at 8,294.10, led by losses in the Financials, Consumer Staples, and Healthcare sectors.</li>
<li>India&#8217;s Nifty 50 closed lower by 0.38% at 23,437.35, and the Nifty 500 slid 1.11%, closing at 21,801.10. The losses were caused by the Power, Real Estate, and Public Sector Undertakings sectors.</li>
<li>China&#8217;s Shanghai Composite was down 1.33% and closed at 3,168.52, while the Shenzhen CSI 300 declined 1.25% and finished the day at 3,732.48.</li>
<li>Hong Kong&#8217;s Hang Seng closed the session lower by 0.92% at 19,064.29.</li>
</ul>
Eurozone at 06:00 AM ET
<ul>
<li>The European STOXX 50 was up 0.09%.</li>
<li>Germany&#8217;s DAX gained 0.20%.</li>
<li>France&#8217;s CAC rose 0.21%.</li>
<li>U.K.&#8217;s FTSE index 100 traded lower by 0.25%.</li>
</ul>
Commodities at 06:00 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 2.25% at $75.81/bbl, and Brent was up 2.46% at $78.83/bbl.</li>
<li>Oil prices rose for a third consecutive week amid supply concerns from sanctions on Russia and Iran, cold weather boosting fuel demand, and inflation worries despite a stronger U.S. dollar.</li>
<li>Natural Gas gained 4.16% to $3.852.</li>
<li>Gold was trading higher by 0.63% at $2,709.21, Silver was up 0.61% to $31.230, and Copper rose 0.69% to $4.3395.</li>
</ul>
Forex at 06:00 AM ET
<ul>
<li>The U.S. Dollar Index was down 0.01% to 109.17, USD/JPY rose 0.01% to 158.08, and USD/AUD gained 0.12% to 1.6159.</li>
<li>The U.S. dollar is on track for a sixth consecutive weekly gain, driven by elevated Treasury yields, inflation concerns, and expectations of strong nonfarm payrolls, signaling potential sustained higher rates.</li>
</ul>
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Dollar Heads For 6th Weekly Gain; Asia Markets Decline, Europe Mixed - Global Markets Today While Us Slept

Needham analyst Matthew Sheerin initiates coverage on Privia Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVA#NASDAQ">PRVA</a>) with a Buy rating and announces Price Target of $25.

PRVA

Needham Initiates Coverage On Privia Health Gr with Buy Rating, Announces Price Target of $25

Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dip from its all-time high of $108,135 on Dec. 17 to its <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42899528/3-bearish-factors-that-could-drag-bitcoin-below-90000">current price around $93,100</a> has prompted questions about the market&#8217;s direction, the impact of government actions and what the future holds under the incoming Trump administration.
Benzinga spoke to several industry experts to take the temperature on Bitcoin&#8217;s near-term future,
<h2 class="wp-block-heading">Market Reversal: Temporary Dip Or A Vibe Shift?</h2>
The recent downturn has investors wondering if this is a minor correction or a sign of a more significant market shift. 
Patrick Liou, Principal of Institutional Sales at crypto exchange Gemini, points to stronger than expected U.S. economic data, especially in the labor market, which triggered a broad sell-off in risk assets, including Bitcoin.
Bradley Howell, Head of Linear Trading at Keyrock, agrees that the Federal Reserve&#8217;s Dec. 18 dot plot, indicating an expectation of only 50 basis points in rate cuts for 2025, impacted all markets.
Howell also noted that slower year-end markets and market participants taking time away from their screens contributed to the downturn, but suggested that the market should have fully priced this in by now.
Julian Beltran, CTO and co-founder of Stabolut, offers a more technical perspective, suggesting that the recent drop represents &#8220;natural profit-taking&#8221; after a period of consolidation near the $100,000 mark.
Beltran emphasizes that &#8220;key metrics remain bullish: ETF inflows continue steadily, institutional adoption is growing and market infrastructure is stronger than in previous cycles.&#8221;
Anastasija Plotnikova, CEO and Cofounder of Fideum, believes that the market has already absorbed the Fed&#8217;s December announcements, viewing the current situation as a &#8220;healthy correction&#8221; within the broader bull cycle. 
She notes the slower rate cut pace, concerns over sticky inflation and overall resilience in the U.S. economy as major sentiment driversL
&#8220;I do not believe there is a drastic vibe shift, this was expected conclusions from the Fed and market has priced it in,&#8221; she said.
Lee Bratcher, President of the Texas Blockchain Council (TBC), echoes this sentiment, describing the reversal as &#8220;a temporary dip in what has been an overall remarkable bull run for crypto.&#8221; 
Bratcher further points to &#8220;increased institutional interest&#8221; and a <a href="https://www.benzinga.com/25/01/42779917/trump-wont-announce-strategic-bitcoin-reserve-via-executive-order-says-analyst-he-would-likely-buy-btc-in-the-background">pro-crypto president</a> as drivers of long-term market strength: 
"With inflation fears remaining high, investors are likely to turn to safe-haven assets which can cause short-term draw downs for risk assets but those are typically short-term jitters that quickly get priced in."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42885028/gary-gensler-says-10000-15000-projects-wont-survive-crypto-market-is-wrapped-up-in-sentiment">Gary Gensler Says 10,000-15,000 Projects Won&#8217;t Survive, Crypto Market Is &#8216;Wrapped Up In Sentiment&#8217;</a>
<h2 class="wp-block-heading">Is The Government Dumping Its Bitcoin A Cause For Concern?</h2>
The announcement that the Department of Justice has <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42890745/us-government-silk-road-bitcoin-holdings-drop-to-0-amid-report-doj-approved-to-sell-6-5-billion-worth-of-crypto">been approved to sell $6.5 billion worth of Bitcoin</a> seized from the Silk Road has created further uncertainty.
Liou stated that this led to a further sell-off in crypto markets when the news broke, noting that the government is yet to proceed with the actual sales.
Howell, while acknowledging that it&#8217;s &#8220;not exactly bullish news,&#8221; puts the sale into context, highlighting the high daily trading volume of Bitcoin. 
"While the roughly 69,420 BTC that the DOJ plans on selling won&#8217;t go unnoticed, as long as they don&#8217;t try to sell it all on one day it should have limited impact on the market,&#8221; Howell noted.
Plotnikova sees a parallel between these sales and previous sales by <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41911120/the-german-government-sold-its-bitcoin-heres-how-much-it-missed-out-on">the German government</a>, emphasizing that &#8220;All that BTC was absorbed by the market and it did affect the price but only temporarily.&#8221;
Plotnikova adds that it was naive to expect that DOJ would allocate these BTC to a <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42531359/is-a-bitcoin-strategic-reserve-a-good-idea-expert-pushes-back-just-buy-btc-yourself">strategic Bitcoin reserve</a>.
She notes that if the sale is not complete until the new administration is sworn in, there might be some unexpected changes.
Bratcher believes that the sales represent a &#8220;moderate sell pressure&#8221; on Bitcoin but encourages the Trump administration to intervene. 
"Trump should put pressure on the Biden Administration not to sell the Bitcoin by making the general public aware of this pending transaction that would truly be the US shooting ourselves in the foot," he said.
<h2 class="wp-block-heading">Is The Inauguration Buy Or Sell The News?</h2>
Looking ahead to the <a href="https://www.benzinga.com/tech/25/01/42898021/google-donates-1-million-to-trump-inauguration-plans-youtube-livestream-pleased-to-support">upcoming presidential inauguration</a>, experts offer varied predictions.
Liou suggests the market is waiting to see the incoming administration's policy moves and that a "direction" could be found soon after the inauguration, depending on the policies and appointments.
Howell believes that Trump&#8217;s presidency is &#8220;fully priced in,&#8221; adding that if something were to prevent Trump from taking office, his VP, J.D. Vance, would likely be even more bullish for the market.
Beltran anticipates a potential &#8220;sell the news&#8221; scenario, where investors might take profits, despite the long-term crypto outlook being cautiously optimistic. 
According to Beltran, the market has likely already priced in <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42773793/trump-taking-office-could-spell-golden-crypto-era-industry-hopes">Trump&#8217;s pro-crypto policies</a>, making a significant pump on inauguration day is unlikely.
Plotnikova expects a period of "de-risking" from markets as investors "wait and see" what Trump will deliver. 
She also adds that the incoming administration is very bullish on crypto assets, preferring a predictable and friendly regulatory environment, and expects bullish sentiment to eventually prevail.
Bratcher sees pro-crypto sentiment, saying that, &#8220;If we see market structure and stablecoin legislation along with a U.S. Strategic Bitcoin Reserve, there is no reason why the bull market wouldn't extend throughout 2025.&#8221;
<h2 class="wp-block-heading">Was $108,000 The Top?</h2>
Asked for their opinion on whether the $108,000 price point was the peak for this cycle, experts m
Howell states a 1% chance, a sentiment echoed by Bratcher, who stated that there is a &#8220;99% chance&#8221; that this is not the high for the cycle.
Beltran admits that $108,000 represents a significant resistance level, but believes higher prices going forward are likely.
Plotnikova is very bullish, saying that $200,000 could be surpassed by the end of 2025. 
While the short-term outlook remains volatile, experts believe that underlying factors support continued growth in the long term. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42897245/bitcoin-silk-road-sales-would-affect-leverage-traders-more-than-holders-analyst-argues">Bitcoin Silk Road Sales Would Affect Leverage Traders More Than Holders, Analyst Argues</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

EXCLUSIVE: Answering Key Questions About Bitcoin's Future 10 Days Before The Inauguration

Needham analyst Matthew Sheerin reiterates Agilon Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) from Hold to Hold.

Needham Reiterates Hold on Agilon Healthto Hold

Global Blue Releases The Monthly Tax Free Shopping Business Update For December 2024: Says Issued Sales In Store Like-for-like Year-on-year Performance Reached +23% In December 2024

Deutsche Bank analyst Cave Montazeri upgrades Equitable Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>) from Hold to Buy and raises the price target from $47 to $58.

Deutsche Bank Upgrades Equitable Hldgs to Buy, Raises Price Target to $58

Telsey Advisory Group analyst Dana Telsey maintains Honest Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNST#NASDAQ">HNST</a>) with a Market Perform and raises the price target from $6 to $7.

HNST

Telsey Advisory Group Maintains Market Perform on Honest Co, Raises Price Target to $7

Alchemab's technology platform uses patient samples from individuals with unusually slow rates of disease progression to identify antibodies associated with resilience.&nbsp;
&nbsp;

Biotech

Health Care

Contracts

General

On Thursday, Alchemab Therapeutics Entered A Collaboration With Eli Lilly To Discover, Develop, And Commercialize Up To Five Therapeutics For Amyotrophic Lateral Sclerosis; Alchemab Will Receive An Undisclosed Upfront Payment And Is Eligible To Receive Milestone Payments, Plus Royalties

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

Inspira Technologies Launches Preparation For Potential Production Ramp-up Of Its INSPIRA ART100 Device In Strategic Readiness Amid Recent Outbreak Of Human Metapneumovirus In China

Comments

ETF Opportunities Trust Brendan Wood TopGun Index ETF

Noticias

Últimas noticias sobre ETF Opportunities Trust Brendan Wood TopGun Index ETF (BATS:BWTG)

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL